Ross Clark Ross Clark

The straight dope | 21 June 2018

The Billy Caldwell case is being exploited by the pro-legalisation lobby for its own ends

issue 23 June 2018

Was there ever a more fatuous contribution to a political debate than Lord Hague following up the case of 12-year-old Billy Caldwell — the boy whose mother says he needs cannabis oil to control his epilepsy — with a demand for recreational cannabis to be legalised? But the former foreign secretary has done us a favour of sorts. He has inadvertently explained why Billy Caldwell has become such a cause célèbre over the past few days: the drug-legalisation lobby has cottoned on to his huge propaganda potential.

The reason why cannabis oil is not licensed for use as a treatment for epilepsy in Britain has nothing to do with the prohibition of cannabis as a recreational drug. Opiates are banned as recreational drugs but that does not prevent their routine use as a painkiller in controlled doses. Moreover, there is a cannabis-derived medicine, Sativex, which is licensed in Britain for pain relief in patients with multiple sclerosis.

Get Britain's best politics newsletters

Register to get The Spectator's insight and opinion straight to your inbox. You can then read two free articles each week.

Already a subscriber? Log in

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in